Case reports of olanzapine treatment of anorexia nervosa

International Journal of Eating Disorders

Volumn 27, Issue 3, 2000, Pages 363-366

  La Via, Maria C ^a   Gray, Nicola ^a   Kaye, Walter H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Anorexia nervosa; Hospitalization; Psychological morbidity

Indexed keywords

FLUOXETINE; OLANZAPINE;

ADOLESCENT; AGITATION; ANOREXIA NERVOSA; ARTICLE; CASE REPORT; CHRONIC DISEASE; FEMALE; FOOD INTAKE; HOSPITALIZATION; HUMAN; MAINTENANCE THERAPY; MORBIDITY; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; ANOREXIA NERVOSA; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; PIRENZEPINE; TREATMENT OUTCOME;

EID: 0034064155     PISSN: 02763478     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-108X(200004)27:3<363::AID-EAT16>3.0.CO;2-5     Document Type: Article

References (18)

1. Anderson, A.E., Morse, C.L., & Santmyer, K.S. (1985). Inpatient treatment for anorexia nervosa. In D.M. Garner & P.E. Garfinkel (Eds.), Anorexia nerovsa and bulimia (pp. 311-343). New York: Guilford.
2. Barr, L.C., Goodman, W.K., Price, L.H., McDougle, C.J., & Charney D.S. (1992). The serotonin hypothesis of obsessive compulsive disorder: Implications of pharmacologic challenge studies. Journal of Clinical Psychiatry, 53 (Suppl. 4), 17-28.
3. Blundell, J.E., & Hill, A.J. (1992). Dexfenfluramine and appetite in humans. International Journal of Obesity, 16, S51-S59.
4. Casey, D.E. (1996). Side effect profiles of new antipsychotics. Journal of Clinical Psychiatry, 57 (Suppl. 11), 38-45.
5. Charney, D.S., Wood, S.W., Krystal, J.H., & Heninger, G.R. (1990). Serotonin function and human anxiety disorders. Annals of the New York Academy of Science, 600, 558-573.
6. Dally, P.J., & Sargant, W. (1960). A new treatment of anorexia nervosa. British Medical Journal, 1, 1770-1773.
7. Grahame-Smith, D.G. (1992). Serotonin in affective disorders. International Clinical Psychopharmacology, 6, S5-S13.
8. Herzog, D.B., Nussbaum, K.M., & Marmor, A.K. (1996). Comorbidity and outcome in eating disorders. Psychiatric Clinics of North America, 19, 943-954.
9. Hoffman, L., & Halmi, K. (1993). Psychopharmacology in the treatment of anorexia nervosa and bulimia nervosa. Psychiatric Clinics of North America, 16, 767-778.
10. Kaye, W.H., Nagata, T., Weltzin, T.E., Hsu, L.K.G., Sokol, M.S., McConaha, C., Plotnicov, K.H., Weise, J., & Deep, D. (in press). Double-blind placebo-controlled administration of fluoxetine in restricting-type anorexia nervosa. American Journal of Psychiatry.
11. Leibowitz, S.F. (1990). The role of serotonin in eating disorders. Drugs, 39, 895-903.
12. McKenzie, J.M., & Joyce, P.R. (1992). Hospitalization for anorexia nervosa. International Journal of Eating Disorders, 11, 235-241.
13. Reus, V.I. (1997). Olanzapine: A novel atypical neuroleptic agent. Lancet, 349, 1264-1265.
14. Russell, G.F.M., Szmukler, G.I., Dare, C., & Eisler, I. (1987). An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Archives of General Psychiatry, 44, 1047-1056.
15. Silber, T.J. (1994). Eating disorders and health insurance. Archives of Pediatric Adolescent Medicine, 148, 785-788.
16. Sullivan, P.F. (1995). Mortality in anorexia nervosa. American Journal of Psychiatry, 152, 1073-1074.
17. Vandereycken, W. (1984). Neuroleptics in the short-term treatment of anorexia nervosa: A double-blind placebo-controlled trial with sulpride. British Journal of Psychiatry, 144, 288-292.
18. Vandereycken, W., & Peirloot, R. (1982). Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa: A double-blind, placebo-controlled, cross-over study. Acta Psychiatrica Scandinavica, 66, 445-450.